首页 › 基金 › ORBIMED ADVISORS LLC › AVBP
ORBIMED ADVISORS LLC 对 AVBP 的持仓历史
ARRIVENT BIOPHARMA INC COM · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 AVBP(ARRIVENT BIOPHARMA INC COM)3,027,328 股,市值约 US$105.2M,约占其申报组合的 2.11%,在其申报持仓中市值排名第 10 位。 ORBIMED ADVISORS LLC 最近 10 个申报季度中有 10 个季度披露了 AVBP 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 AVBP 的持仓演变
ORBIMED ADVISORS LLC 于 Q1 2024 首次披露 AVBP 持仓:3,027,328 股(约 US$54.1M)。 该持仓在 Q2 2026 达到峰值 3,027,328 股,市值约 US$105.2M。 在 10 次申报中,ORBIMED ADVISORS LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 3,027,328 股、市值约 US$105.2M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 3.03M | $54.07M | 新进 |
| Q2 2024 | 3.03M | $56.16M | 持有 |
| Q3 2024 | 3.03M | $71.14M | 持有 |
| Q4 2024 | 3.03M | $80.65M | 持有 |
| Q1 2025 | 3.03M | $55.98M | 持有 |
| Q2 2025 | 3.03M | $65.90M | 持有 |
| Q3 2025 | 3.03M | $55.85M | 持有 |
| Q4 2025 | 3.03M | $60.91M | 持有 |
| Q1 2026 | 3.03M | $69.84M | 持有 |
| Q2 2026 | 3.03M | $105.17M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AVBP 与 13F 数据
AVBP(ARRIVENT BIOPHARMA INC COM)属于医疗保健行业。我们追踪的基金中还有 60 只申报持有 AVBP,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$156.9M), INFINITUM ASSET MANAGEMENT, LLC (US$154.2M), 高瓴资本 (US$136.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AVBP 的基金
- MONTANOVA CAPITAL, LLC 4.52M 股 · $156.87M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 4.44M 股 · $154.19M · Q2 2026
- 高瓴资本 3.93M 股 · $136.50M · Q2 2026
- Octagon Capital Advisors LP 1.97M 股 · $68.47M · Q2 2026
- Sofinnova Investments, Inc. 1.70M 股 · $58.95M · Q2 2026
- Vivo Capital, LLC 1.68M 股 · $58.44M · Q2 2026
- Novo Holdings A/S 1.50M 股 · $52.11M · Q2 2026
- General Catalyst Group Management, LLC 1.49M 股 · $51.93M · Q2 2026
- Logos Global Management LP 1.00M 股 · $34.74M · Q2 2026
- HSG Holding Ltd 663.31K 股 · $23.04M · Q2 2026
- Foresite Capital Management VI LLC 301.34K 股 · $10.47M · Q2 2026
- Seven Fleet Capital Management LP 246.61K 股 · $8.57M · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held AVBP?
ORBIMED ADVISORS LLC has disclosed AVBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is ORBIMED ADVISORS LLC's current position in AVBP?
As of Q2 2026, ORBIMED ADVISORS LLC holds 3.03M shares of AVBP (ARRIVENT BIOPHARMA INC COM), valued at $105.17M, representing 2.11% of its reported portfolio and ranking #10.
Has ORBIMED ADVISORS LLC been buying or selling AVBP?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in AVBP. The position peaked in Q2 2026 at 3.03M shares.
Which other funds hold AVBP?
Other major institutional holders of AVBP include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, 高瓴资本, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.